These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7547385)

  • 1. Expression of stem cell factor in cutaneous mastocytosis.
    Hamann K; Haas N; Grabbe J; Czarnetzki BM
    Br J Dermatol; 1995 Aug; 133(2):203-8. PubMed ID: 7547385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas.
    Haas N; Hamann K; Grabbe J; Algermissen B; Czarnetzki BM
    Arch Dermatol Res; 1995; 287(3-4):242-8. PubMed ID: 7541189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of SCF in the dermis is a prognostic factor for the regression of urticaria pigmentosa.
    Onuma H; Matsui C; Morokashi M
    Eur J Dermatol; 1999 Dec; 9(8):629-32. PubMed ID: 10586131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis.
    Hartmann K; Hermes B; Rappersberger K; Sepp N; Mekori YA; Henz BM
    Br J Dermatol; 2003 Sep; 149(3):554-9. PubMed ID: 14510988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two novel mast cell phenotypic markers, monoclonal antibodies Ki-MC1 and Ki-M1P, identify distinct mast cell subtypes.
    Hamann K; Haas N; Grabbe J; Welker P; Czarnetzki BM
    Br J Dermatol; 1995 Oct; 133(4):547-52. PubMed ID: 7577581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastocytosis and the skin.
    Soter NA
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):537-55, vi. PubMed ID: 10909039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis.
    Longley BJ; Morganroth GS; Tyrrell L; Ding TG; Anderson DM; Williams DE; Halaban R
    N Engl J Med; 1993 May; 328(18):1302-7. PubMed ID: 7682288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased cutaneous expression of stem cell factor and of the p75NGF receptor in urticaria.
    Hermes B; Zuberbier T; Haas N; Henz BM
    Br J Dermatol; 2003 Mar; 148(3):411-7. PubMed ID: 12653731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mastocytosis in children: clinicopathological study based on 35 cases.
    Kiszewski AE; Alvarez-Mendoza A; Ríos-Barrera VA; Hernández-Pando R; Ruiz-Maldonado R
    Histol Histopathol; 2007 May; 22(5):535-9. PubMed ID: 17330808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric mastocytosis.
    Hartmann K; Metcalfe DD
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):625-40. PubMed ID: 10909043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
    Hollmann TJ; Brenn T; Hornick JL
    Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
    Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
    Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous mastocytosis].
    Flageul B
    Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human dermal endothelial cells express membrane-associated mast cell growth factor.
    Weiss RR; Whitaker-Menezes D; Longley J; Bender J; Murphy GF
    J Invest Dermatol; 1995 Jan; 104(1):101-6. PubMed ID: 7528242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.
    Wiechers T; Rabenhorst A; Schick T; Preussner LM; Förster A; Valent P; Horny HP; Sotlar K; Hartmann K
    J Allergy Clin Immunol; 2015 Dec; 136(6):1581-1590.e3. PubMed ID: 26152315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical demonstration of migration inhibitory factor in different types of urticaria.
    Czarnetzki BM; Zwadlo-Klarwasser G; Bröcker EB; Sorg C
    J Invest Dermatol; 1989 Oct; 93(4):471-4. PubMed ID: 2476510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basophil/mast cell precursors in mast cell proliferative disorders.
    Denburg JA; Telizyn S; Ahlstedt S; Olafsson JH; Roupe G; Bienenstock J
    Clin Invest Med; 1986; 9(1):21-5. PubMed ID: 3955917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation.
    Ceponis A; Konttinen YT; Takagi M; Xu JW; Sorsa T; Matucci-Cerinic M; Santavirta S; Bankl HC; Valent P
    J Rheumatol; 1998 Dec; 25(12):2304-14. PubMed ID: 9858422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.
    Hartmann K; Artuc M; Baldus SE; Zirbes TK; Hermes B; Thiele J; Mekori YA; Henz BM
    Am J Pathol; 2003 Sep; 163(3):819-26. PubMed ID: 12937123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.